Condition
Urinary tract infections and interstitial nephritis
Clinical trials and treatment information for Urinary tract infections and interstitial nephritis
Treatment Rankings
Ranked by evidence volume first. Medicine has spent centuries ranking things by vibes. This is an improvement.
Comparative Safety Scale(Higher is safer)
Time to Effect
1-2 days
Duration
5-7 days
Response Rate
90%
Remission Rate
85%
Number Needed to Treat (NNT)
3
Common Side Effects:
Annual Cost of Care
Drug Cost
$20
Monitoring
$600
Side Effects
$5
Total Annual
$625
Cost-Effectiveness
EXCELLENTCost per Remission
$29
Cost per Responder
$28
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
1-2 days
Duration
3 days
Response Rate
85%
Remission Rate
80%
Number Needed to Treat (NNT)
4
Common Side Effects:
Annual Cost of Care
Drug Cost
$15
Monitoring
$600
Side Effects
$5
Total Annual
$620
Cost-Effectiveness
EXCELLENTCost per Remission
$25
Cost per Responder
$24
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
1-2 days
Duration
single dose
Response Rate
85%
Remission Rate
78%
Number Needed to Treat (NNT)
4
Common Side Effects:
Annual Cost of Care
Drug Cost
$45
Monitoring
$600
Side Effects
$2
Total Annual
$647
Cost-Effectiveness
EXCELLENTCost per Remission
$60
Cost per Responder
$55
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
1-2 days
Duration
5-7 days
Response Rate
85%
Remission Rate
78%
Number Needed to Treat (NNT)
4
Common Side Effects:
Annual Cost of Care
Drug Cost
$25
Monitoring
$600
Side Effects
$5
Total Annual
$630
Cost-Effectiveness
EXCELLENTCost per Remission
$38
Cost per Responder
$35
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
1-2 weeks
Duration
4-12 weeks, with taper
Response Rate
70%
Remission Rate
55%
Number Needed to Treat (NNT)
3
Common Side Effects:
Annual Cost of Care
Drug Cost
$75
Monitoring
$350
Side Effects
$275
Total Annual
$700
Cost-Effectiveness
EXCELLENTQALYs Gained
1
Cost per Remission
$1,273
Cost per Responder
$1,000
Clinical Trial Phases: